GB0208925D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB0208925D0
GB0208925D0 GBGB0208925.8A GB0208925A GB0208925D0 GB 0208925 D0 GB0208925 D0 GB 0208925D0 GB 0208925 A GB0208925 A GB 0208925A GB 0208925 D0 GB0208925 D0 GB 0208925D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0208925.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB0208925.8A priority Critical patent/GB0208925D0/en
Publication of GB0208925D0 publication Critical patent/GB0208925D0/en
Priority to PCT/GB2003/001583 priority patent/WO2003087143A2/en
Priority to AU2003224274A priority patent/AU2003224274A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742Bactericidal/Permeability-increasing protein [BPI]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0208925.8A 2002-04-12 2002-04-12 Polypeptide Ceased GB0208925D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0208925.8A GB0208925D0 (en) 2002-04-12 2002-04-12 Polypeptide
PCT/GB2003/001583 WO2003087143A2 (en) 2002-04-12 2003-04-11 Human polypeptides having antibacterial activity
AU2003224274A AU2003224274A1 (en) 2002-04-12 2003-04-11 Human polypeptides having antibacterial activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208925.8A GB0208925D0 (en) 2002-04-12 2002-04-12 Polypeptide

Publications (1)

Publication Number Publication Date
GB0208925D0 true GB0208925D0 (en) 2002-05-29

Family

ID=9935101

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0208925.8A Ceased GB0208925D0 (en) 2002-04-12 2002-04-12 Polypeptide

Country Status (3)

Country Link
AU (1) AU2003224274A1 (en)
GB (1) GB0208925D0 (en)
WO (1) WO2003087143A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192221A1 (en) * 2003-12-04 2005-09-01 Mccray Paul B.Jr. Methods and compositions related to plunc polypeptides
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028420A1 (en) * 1996-12-23 1998-07-02 Human Genome Sciences, Inc. Human parotid secretory protein
WO1999002546A1 (en) * 1997-07-08 1999-01-21 Human Genome Sciences, Inc. 123 human secreted proteins
CA2316864A1 (en) * 1998-01-02 1999-07-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU2001271589A1 (en) * 2000-06-30 2002-01-14 Zymogenetics Inc. Mammalian secreted proteins

Also Published As

Publication number Publication date
AU2003224274A1 (en) 2003-10-27
WO2003087143A3 (en) 2004-03-18
WO2003087143A2 (en) 2003-10-23
AU2003224274A8 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
GB0208331D0 (en) Proteins
GB0209884D0 (en) Proteins
AU2003290563A8 (en) Leptin-related peptides
GB0201679D0 (en) Polypeptide variants
GB0218977D0 (en) Polypeptide
EP1614695A4 (en) Polypeptide
EP1487874A4 (en) Falp proteins
GB0212067D0 (en) Proteins
GB0223193D0 (en) Polypeptide
GB0202275D0 (en) Peptide
GB0208925D0 (en) Polypeptide
AU2003270055A8 (en) Neurotransmission-associated proteins
GB0210746D0 (en) Peptide
AU2003300785A8 (en) Carbohydrate-associated proteins
EP1477559A4 (en) Novel polypeptide
GB0222181D0 (en) Polypeptide
GB0219720D0 (en) Polypeptide
GB0219980D0 (en) Peptides
AU2003236908A8 (en) Proteins
AU2003295760A8 (en) Organelle-associated proteins
GB0216757D0 (en) Proteins
GB0202221D0 (en) Novel polypeptide
GB0303186D0 (en) Polypeptide
GB0303135D0 (en) Polypeptide
GB0308088D0 (en) Polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)